L2-305 - Once a Day Versus Twice a Day Sitafloxacin (STFX) for Microbiological Cure of Women with Cervicitis by "Chlamydia trachomatis"

Trial Profile

L2-305 - Once a Day Versus Twice a Day Sitafloxacin (STFX) for Microbiological Cure of Women with Cervicitis by "Chlamydia trachomatis"

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Sep 2012

At a glance

  • Drugs Sitafloxacin (Primary)
  • Indications Chlamydial infections; Uterine cervicitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top